Coherus Biosciences | Lucro Operacional

Preço das Ações
2.11
Mudança Diária
0.05 2.43%
Mensal
27.88%
Anual
90.09%
Q1 Previsão
2.39




Lucro Operacional Alterar Data
AbbVie USD 5.81B 1.23B 2025-12
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Akebia Therapeutics USD 13.51M 27.82M 2025-03
ALKERMES USD 89.08M 3.9M 2025-09
Alnylam Pharmaceuticals USD -29.96M 13.76M 2025-09
Amarin USD -1.7M 8.47M 2025-09
Amgen USD 3.96B 464M 2025-12
Baxter International USD 201.2M 70.8M 2025-09
Biogen USD 659.6M 192.2M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Coherus Biosciences USD -45.43M 3.13M 2025-03
Eli Lilly USD 8.99B 599.9M 2025-12
Fujifilm JPY 89.96B 6.77B 2025-12
Gilead Sciences USD 3.51B 810M 2025-09
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Merck USD 6.24B 318M 2025-12
Myriad Genetics USD -23.3M 10.8M 2025-09
Pacira USD 13.15M 2.92M 2025-09
Perrigo USD 93.4M 37.8M 2025-09
Pfizer USD 4.65B 3.99B 2025-12
PTC Therapeutics USD 3.49M 38.35M 2025-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Teva Pharmaceutical Industries USD 487M 581M 2025-12
Vertex Pharmaceuticals USD 1.24B 84.6M 2025-09
Xencor USD -47.52M 14.35M 2025-09
Zoetis USD 936M 63M 2025-09


Coherus Biosciences Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.